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Some sublines of Bio-Breeding (BB) rats spontaneously develop type 1, insulin-
dependent diabetes (1) . Various forms of immunosuppression can protect the
diabetes-prone BB rats (BB-DP rats)' from diabetic disease (2-4) . This suggests
an immune etiology . BB-DP rats also have several striking abnormalities in
thymus-derived (T) lymphocyte immune responses . BB-DP T cells proliferate
poorly in response to alloantigen in vitro (5) and fail to generate CTL responses
(6) . These T cell dysfunctions appear to predispose the animals to disease
development because when the dysfunctions are reversed the animals are pro-
tected from disease (7-9) . Other investigators have concluded that the T cell
dysfunctions appear to be of bone marrow origin (10), the inference being that
they occur at the level of T cell precursors in the bone marrow and are
presumably not influenced by the thymus .
The experiments in this report provide evidence for another interpretation,
namely, that the defective T cell responses are due to bone marrow-derived
cells that (a) are not T cell precursors, and (b) influence the maturation and
eventual function of normal thymocyte precursors by residing in the thymus
during T cell maturation .
Materials and Methods
Rats .
￿
The Barbara Davis Center for Childhood Diabetes (BDCCD) has a colony of
specific pathogen-free (SPF) BB-DP rats . They were derived in Basel, Switzerland from
a breeding nucleus kindly supplied by Drs . A. Naji andC. F. Barker of the University of
Pennsylvania (Philadelphia, PA) . The rats have typed as RT 1° at the MHC. Inbred DA
(RT la) and Fisher 344 (RT 1'") rats were obtained from Trudeau Institute (Saranac
Lake, NY)and Taconic Farms, Inc . (Germantown, NY), respectively . Strain PVG (RT 1`)
were purchased from Bantin and Kingman (Freemont, CA). Nondiabetes-prone DA/BB
F1 animals were bred at theBDCCD.
Bone Marrow and Thymus Donors .
￿
T cell-depleted bone marrow was harvested from
adult BB or DA/BB FI donors 8-10 wk old. These marrow donors had previously been
adult thymectomized and treated for 7 d (1 ml intraperitoneally) with OX-19 antibody
supernatant . The OX-19 marker is the LyI equivalent in the mouse and is present on all
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' Abbreviations used in this paper:
￿
atxbm, adult thymectomized, lethally irradiated, and bone
marrow reconstituted ; DP, diabetes prone ; DR, diabetes resistant ; dGua, 2-deoxyguanosine ; IMDM,
Iscove's modified Dulbecco's medium ; SPF, specific pathogen free ; TDL, thoracic duct lymphocyte .
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mature peripheral T cells in the rat. This in vivo antibody protocol reduces the percentage
of OX-19' cells in the periphery (11). The donors were also thoracic duct cannulated as
described (5) and drained for a further 3-5 d before marrow cells were harvested. The
thoracic duct drainage procedure is thought to recruit any remaining mature T lympho-
cytes into the periphery from their residence in the marrow (12).
Fetal thymus was obtained from DA/BB F 1 or BB donors of 18-20 d gestation. The
tissue was dissected asceptically and freed from adhering tissues. It received 2,000 rad of
irradiation before transplantation to delete the tissue of resident DA/BB F 1 thymocytes.
The equivalent of one whole thymus was transplanted per recipient.
Thymus Culture in 2 Deoxyguanosine (dGua).
￿
Thymus tissue was cultured in dGua using
a modification of the method first described by Jenkinson et al. (13). Individual thymus
lobes were dissected into four equal fragments and placed on the surface of sterile strips
of Durapore HVLP filter (Millipore/Continental Water Systems, Bedford, MA). The
filter strips were supported on Gelfoam sponge (Upjohn Co., Kalamazoo, MI) soaked in
RPMI 1640 culture medium supplemented with 10% FCS, 2 mM glutamine, 10 mM
Hepes buffer, 50,aM 2-ME, 100 U/ml penicillin, and 100 ug/ml streptomycin. One or
two filter/sponge assemblies containing 4-8 thymus lobes were placed in a 10-cm petri
dish with 15 ml of culture medium containing 4 mM dGua (Sigma Chemical Co., St.
Louis, MO) and cultured for 5-7 d.
T Cell-depleted Recipients.
￿
7-wk-old BB and DA/BB F 1 rats were adult thymectomized
and allowed to recover for at least 7 d. After this recovery period they were subjected to
lethal whole body irradiation (950 and 1,050 rad, respectively). Irradiated animals were
immediately reconstituted with 50 X 106 T cell-depleted bone marrow cells given
intravenously. Each animal was given syngeneic marrow. 7 d later these adult thymecto-
mized (at), lethally irradiated (x), and bone marrow (bm) reconstituted animals (atxbm)
received a transplant beneath the kidney capsule of one whole fetal thymus. At various
times after transplantation, the recipients had a cannula placed into the thoracic duct and
thoracic duct lymphocytes (TDLs) were collected overnight and tested for surface phe-
notype and functional activity.
Cell Staining.
￿
^+2 X 106 TDLs were stained with mAb supernatants OX-19 (rat pan-T
cell marker), OX-8 (rat CD8 marker for class I MHC antigen-reactive T cells), or W3/25
(rat CD4 marker for class II MHC antigen-reactive T cells) (14). Antibody was derived
from cell lines generously provided by Dr. A. Williams (Oxford, England). TDLs were
incubated in 1 ml of supernatant at 4°C for 30 min and then washed three times. This
was followed by a further incubation with FITC-conjugated sheep anti-mouse (IgG
F[ab']2) antibody diluted 1 :100 (Cappel Laboratories, Malvern, PA). For background
controls, cells were treated with the second antibody alone. After a further three washes,
the cells were fixed in 1 % paraformaldehyde and the percentage of positive cells was
determined using an EPICS C flow cytometer (Coulter Electronics Inc., Hialeah, FL).
Mixed Leukocyte Reaction.
￿
TDLs were cultured in Iscove's modified Dulbecco'smedium
(IMDM) supplemented with 2 mM glutamine, penicillin/streptomycin, 50'M 2-ME, and
5% normal rat serum as described (15). Responder cells (beginning at 3 X 105 per well)
were plated at three serial half-dilutions in 96-well U-bottomed plates. Stimulator cells
were derived from lymph nodes and irradiated with 2,000 rad. A constant number of
stimulator cells (3 X 10 per well) were added to a final volume of 0.2 ml. After 3 d of
incubation, 0 .025 ml [5H]thymidine (25 uCi/ml) was added per well and incubated for a
further 18 h. Cells were then harvested onto glass-fiber filters and counted for 1 min in
a ,S-ray scintillation counter. Values are recorded as the mean cpm of triplicate samples;
the SE did not exceed 10% of the mean.
Generation ofCytotoxic T Lymphocytes (CTL) and5'Cr-release Assay.
￿
CTLs were generated
from TDLs cultured in the presence of either DA/BB F1 or Fisher irradiated lymph node
cells as previously described (15). Usually 10 X 106 TDLs were mixed with 25 X 106
stimulator cells and cultured for 6 d in IMDM supplemented with 10% FCS and 5% T
cell growth factor (16). The final volume was 25 ml. Day 6 effector cells were then washed
and plated in triplicate into V-bottomed plates at four serial half-dilutions. A constant
number of 5'Cr-labeled target cells (5 X 105/well) were added to a final volume of 0 .125134
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TABLE I
Comparison ofMixed Leukocyte Responses between Diabetes-proneBB
and Diabetes-resistant Strains
* Number of responder cells X 10'5 per well .
$ Thoracic duct lymphocytes from BB-DP rats were stimulated with populations
allogeneic and MHC-incompatible to BB rats as described in Materials and
Methods. Values refer to the mean cpm of triplicate cultures when pulsed with
[ sH]thymidine 3 d after culture initiation . The SE did not exceed 10% of the
mean . Strains Fisher, PVG, DA, and BB-DR are diabetes resistant.
ml . Target cells were generated by culturing lymph node cells for 2-3 d in IMDM
supplemented with 5 Ag/ml Con A . The plates were incubated for 4 h at 37 °C, centri-
fuged, and half of the supernatant was collected for measurement of radioactivity . The
values are recorded as the mean percent specific release from triplicate samples .
Test for Chimerism.
￿
TDLs from unmanipulated BB, DA/BB F1, and thymus-trans-
planted rats were resuspended at 107 cells/ml . 25,al of cell suspension was added to 50 ul
of twofold serially diluted antiserum in 96-well U-bottomed microtiter plates. (Anti-DA
and anti-BB polyclonal antisera were generated by immunizing MHC-incompatible rats
with spleen cells .) After the addition of 25 j1 of rabbit C (Cappel Laboratories), the plates
were incubated for 1 h at 37°C after which time 10,ul of trypan blue stain was added and
the percentage of dead cells enumerated . Values refer to percentage of dead cells at
plateau levels of antibody .
Results
Experimental Approach.
￿
We have published previously that TDLs from BB-
DP rats proliferate poorly in response to alloantigen in vitro (5) . Table I presents
Exp . Responder
TDLs
Responder
cells*
Stimulator cells (3 X 10 5 cells/well)
1 _DA None
BB-DP 3.0 6,9581 3,298
1 .5 2,636 1,180
0.75 1,998 221
Fisher 3 .0 41,691 7,298
1 .5 37,415 5,004
0.75 22,649 1,863
2 _DA None
BB-DP 3 .0 6,074 2,585
1 .5 4,007 938
0.75 3,669 385
PVC, 3.0 81,751 7,831
1 .5 94,378 2,217
0.75 57,720 1,886
3 Fisher None
BB-DP 3 .0 5,110 315
1 .5 1,525 128
0.75 179 86
BB-DR 3 .0 51,262 10,363
1 .5 103,928 980
0.75 99,808 249
DA 3 .0 97,552 11,801
1 .5 107,721 4,845
0.75 29,599 258TABLE II
TDL Surface Phenotype in Normal and Thymus-transplanted
BBatxbmFlx Rats
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Cells were stained for OX-19 (pan T cell), OX-8 (class I MHC-reactive cell), and
W3/25 (class II MHC-reactive cell) surface markers.
Numbers represent the absolute percentage of positive cells (test minus back-
ground). The percentbackground staining for each of the five animals was 5.2,
19.2, 14.2, 14.5, and 15.6, respectively, where background = %-positive cells
stained with FITC-labeled second antibody alone.
recent data from three separate experiments that confirm this. In experiments
1 and 2, TDLs from BB-DP rats are compared with TDLs from normal PVG
and Fisher rats for their proliferative response to alloantigen in vitro. In exper-
iment 3 the BB-DP response is compared with that of a diabetes-resistant strain
of BB (BB-DR) as well as a normal DA rat. In each case the BB-DP response is
poor, ranging from 5 to 16% of that from a normal or BB-DR response.
Our first goal was to design experiments to test whether we could influence
these characteristic T cell responses of normal and BB-DP rats by transplantation
of thymus tissue . To accomplish this first goal we prepared "B" rats; i.e., rats
that are devoid of T cell function. BB-DP rats were adult thymectomized, lethally
irradiated, and reconstituted with T cell-depleted bone marrow from syngeneic
donors as described in Materials and Methods. These T cell-depleted animals
(BBatxbm) were transplanted with thymus tissue from FI animals where one
parent was BB-DP and the other was a normal, nondiabetes-prone, strain DA.
The DA/BB F 1 exhibits T cell functions like those of normal rats and does not
develop diabetes.
TDL Surface Phenotype.
￿
7 wk after transplantation with y-irradiated F 1 thy-
mus, the BBatxbm rats had a cannula surgically implanted into their thoracic
duct and TDLs were collected overnight. The TDLs were stained with mouse
monoclonal antibodies specific for rat T cell antigens and compared with those
from normal F1 and unmanipulated BB rats. The monoclonals used were 0X-
19 (pan-T), OX-8 (CD8), and W3/25 (CD4). In Table II it can be seen that
DA/BB F1'TDLs have a T cell profile of normal rats. More than three-quarters
of the TDLs are OX-19'T cells, and the class II MHC antigen reactive (W3/25')
population is roughly twice the class I MHC antigen reactive (OX-8') population.
In addition, the sum of OX-8+ and W3/25+ equals the percentage of OX-19'
cells. On the other hand, TDLs from BB-DP rats show a significantly reduced
number of OX-19+ cells which is roughly equal to the number of W3/25+ cells.
"Thus the small percentage of cells that are OX-8+ are probably OX 19- and are
thought to be NK cells (6). TDLs from the three BBatxbmFIx continued to
Rats
OX-19
Positive cells
OX-8 W3/25
DA/BB F1 (unmanipulated) 73.7 20.8 45.5
BB-DP(unmanipulated) 19.2 5.6 19.4
BBatxbmFlx No. 1 10.1 0 9.4
2 16.0 7.7 14.8
3 19.4 2.6 19.513 6
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(A) TDLs from diabetes-resistant DA/BB F1 and diabetes-prone BB were com-
pared in a mixed leukocyte reaction with TDLs from BB rats that had been adult thymecto-
mized, lethally irradiated, and reconstituted with T cell-depleted syngeneic bone marrow,
and grafted with a 7-irradiated DA/BB 171 thymus (BBatxbmFlx). BB+0 refers to the
proliferative response of BB TDLs withouttheaddition ofallogeneic (Fisher) stimulators. This
background response was higher than the background responses of all of the BBatxbmFlx
animals. (B) The data from A are replotted to correct for the percentage of responder cells
that are OX-19+(pan-T cell marker).
show reduced numbers of OX-19+ T cells and few, if any, OX-8 + cells. The
profile appears remarkably similar to the one observed with unmanipulated BB-
DP TDLs. Once again, the W3/25+ population roughly equaled the OX-19+
population. The higher background staining observed when the cells are labeled
with the FITC-tagged sheep anti-mouse IgG (all monoclonals used were raised
in mice) is a consistent observation and is not due to Fc binding as the FITC-
labeled antibody is an F(ab')2 fragment. This high background, characteristic of
BB-DP rats is also present on TDLs from BBatxbmFIx.
Restoration ofMLR in Thymus-transplanted BB-DPRats.
￿
When TDLs from the
same BBatxbm animals were tested (7 wk after transplantation with F1 thymus
tissue) we observed that all three had an enhanced proliferative response to
third-party stimulator cells compared to unmanipulated BB-DP rats (Fig. 1A).
Although the proliferative response of the TDLs from these Fl thymus-trans-
planted animals did not reach the levels observed for TDLs from normal DA/BB
Fl rats, it was clearly improved over the response of untreated BB-DP rats. This
was despite the fact that all three animals had markedly reduced numbers of
OX-19+ T cells as assessed by flow cytometry (Table II). Because the absolute
number of T cells differed between the populations tested in Fig. IA (^-73% for
normal and 19% for BB-DP rats), we replotted the abscissa as the number of
OX-19+ responder cells per well rather than the number of TDLs per well.
When plotted in this manner the curves for two of the three BBatxbmFIx rats
appeared to be on the same slope as the curve for T cells from a normal animal
(Fig. 1B). The response of the unmanpulated BB animal remained poor.
Therefore on a cell-for-cell basis it could be argued that the T cells in the F1
thymus-grafted BBatxbm animals responded like T cells from normal ratherN
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Percent specific lysis of Fisher (*) and DA/BB F1 (p) targets by normal and
thymus transplanted (#1 from Fig. 1) rats. Each point represents the mean from triplicate
samples when TDLs were cultured with Fisher or DA/BB F1 stimulator cells and tested for
specific cytolysis of targets from the same haplotype as those used to stimulate the response.
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than BB-DP rats. This representation of the data also shows that the poor BB-
DP proliferative response is not simply due to a reduction in the absolute numbers
of T cells. Even correcting for the relative numbers of T cells per culture does
not restore the BB-DP response to the range of normal rats.
Restoration of CTLs in Thymus-transplanted BB-DP Rats.
￿
The same BBatxbm
animals that expressed improved proliferative responses to alloantigen after
transplantation with F1 thymus grafts were also tested for their capacity to
generate CTLs . Failure to generate CTLs is the other obvious T cell dysfunction
in the BB-DP rat. TDLs from untreated BB-DP and DA/BB rats were compared
with F 1 thymus-transplanted BB-DP rats. TDLs from all animals were cultured
with strain Fisher (allogeneic and MHC-incompatible to both DA and BB)
stimulator cells for 6 d as described in Materials and Methods . As expected,
TDLs from normal DA/BB F 1 rats stimulated with Fisher cells show a significant
level of specific lysis of Fisher targets whereas TDLs from unmanipulated BB
rats show no detectable cytolysis (Fig. 2). The BBatxbm animals grafted with
irradiated DA/BB F1 thymus (F 1 x) express a significant level of specific cytolytic
activity when stimulated with and tested against Fisher targets . Representative
data from one thymus-transplanted rat is shown in Fig. 2 . No lysis of DA/BB F 1
targets was observed when the BBatxbmFIx TDL were stimulated with DA/BB
F 1 alloantigen .
Testfor Chimerism in Thymus-transplanted BB-DP Rats.
￿
Although the thymus
tissue was irradiated with 2,000 rad before transplantation to presumably kill
any F1 thymocytes that were present in the tissue, we tested whether TDLs from
BBatxbmF l x were sensitive to lysis with antibodies to DA alloantigen. If they
were it would suggest that some of the peripheral lymphocytes present in the
TDLs of the grafted animals were of DA/BB F1 rather than BB origin. To test
this, we treated the TDLs with polyclonal anti-DA antiserum plus rabbit C.
While TDLs from normal DA/BB F1 are all lysed by this procedure, lysis of cells
from the unmanipulated and thymus-transplanted rats is roughly equivalent to13 8
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TABLE III
Test for Chimerism in Thymus-transplanted BBatxbmFlx Rats
Rats
Dead cells
TDLs were treated with either anti-DA or anti-BB polyclonal antiserum in the
presence of rabbit C.
the complement-treated alone control (Table III). Therefore the proliferative
responses observed in the thymus-transplanted BBatxbm rats would appear to
be from cells ofthe BB haplotype.
Rationalefor Subsequent Experiments.
￿
Having established that a thymus trans-
plant from a normal rat donor can influence T cell function in BB-DP rats,
another goal was to determine if this improved T cell function was mediated by
bone marrow-derived cells of the thymic donor haplotype which resided in the
thymus at the time of transplant. Our rationale for raising this question was
based on two previously published experimental observations. The first was that
another laboratory had transplanted BB-DP animals with thymus grafts from a
diabetes-resistant line of BB (BB-DR) and concluded that the T cell dysfunction
mapped to the marrow rather than the thymus donor (10). The second evolved
from recent publications by several other laboratories using the drug dGua. It
has been shown that dGua treatment causes selective depletion oflymphoid cells
(13) and cells of the macrophage and/or dendritic cell lineages (17). This
treatment spares the thymic epithelial cells thus permitting the maturation ofT
cells restricted to the MHC of the thymic epithelium (17). However, when the
marrow-derived thymocytes in these newly reconstituted thymus grafts are tested
for function, they are not tolerant to thymic donor alloantigens as assessed by
proliferative responses or the generation of cytotoxic T lymphocytes (13, 18,
19). Thymocytes isolated from thymus tissue that was not treated with dGua are
tolerant. One conclusion from these studies is that tolerance to self-antigens is
critically dependent on a dGua-sensitive population ofcells which resides in the
thymus.
Our working hypothesis was that the enhanced proliferative response observed
in BBatxbm transplanted with F1 thymus tissue was due to the presence of F1
cells which were resistant to the 2,000 rad ofirradiation to which the 171 thymus
hadbeen subjected before transplantation. These cells were most likely radiation-
resistant cells of the macrophage and/or dendritic cell lineages rather than
thymocytes. This hypothesis would provide an explanation for the previously
published study concluding that the T cell dysfunction in BB-DP rats is mapped
to the bone marrow. It would also predict that (a) the T cell response of BB-DP
rats transplanted with FI thymus grafts would deteriorate with time as the
thymus became repopulated with BB-DP macrophage and/or dendritic cells; and
Calone Anti-DA + C Anti-BB + C
DA/BB F1 (unmanipulated) 12.1 100 100
BB-DP (unmanipulated) 16.6 12.5 100
BBatxbmFIx No. 1 9.0 13.6 100
2 13.1 12.6 100
3 22.1 26.0 100GEORGIOU ET AL .
￿
13 9
FIGURE 3 . Proliferative re-
sponses are compared between
normalPVGandBB-DP rats with
a BBatxbm transplanted with a
DA/BB F1 thymus cultured with
dGua (BBatxbmFIdGua) . Repre-
sentativedata areshownfrom one
animal tested at 7 wk afterthymus
transplantation .
(b) that the FI thymus graft would be ineffective in reversing the T cell
dysfunction if treated with dGua before transplant . The experiments that follow
provide evidence that supports these predictions . The four main experimental
groups tested were : (a) BBatxbm rats transplanted with y-irradiated F 1 thymus
(BBatxbmFlx ; data shown above); (b) BBatxbm rats transplanted with dGua-
treated F 1 thymus (BBatxbmF1dGua) ; (c) DA/BBatxbm rats transplanted with
-y-irradiated BB thymus (FlatxbmBBx) ; and (d) DA/BBatxbm rats transplanted
with dGua-treated BB thymus (F latxbmBBdGua) .
Response ofBBatxbmFI dGua at 7 wk .
￿
According to our working hypothesis,
the enhanced proliferative response of BBatxbmF 1 x is due to the presence of
radioresistant bone marrow-derived cells which migrate to the thymus . These
cells do not appear to beT cell precursors as there was no evidence ofchimerism
in the peripheral T cell pool (Table III) . If these cells are poisoned by culture in
dGua then transplantation of dGua-treated F1 thymus tissue should not have the
same effect as y irradiation-treated F 1 thymus tissue because the F 1 thymus
should be repopulated with BB-DP marrow-derived cells . To test this, BBatxbm
were prepared as before and transplanted with an F1 thymus . Instead of y
irradiation the thymus tissue was cultured for 5-7 d in the presence ofdGua as
described in the Materials and Methods . At the dose used in this experiment we
observed that the dGua reduces the in vitro thymocyte proliferation assay to
background (data not shown) . When examined histologically there was no
evidence of thymocytes present in the dGua-treated tissue . At 7 wk after
transplanting BBatxbmF ldGua, we tested for proliferative response to alloanti-
gen . The response was similar to that observed for untreated BB-DP (Fig . 3) .
The weak responses were not changed by data manipulations which corrected
for the percentage of OX-19+ cells although OX-19+ cells were clearly present
(data not shown) .
Response ofFlatxbmBBx and FlatxbmBBdGua at 7 wk.
￿
The results thus far
suggest that an F 1 thymus graft can lead to an improved T cell response and
that this enhanced response is due to the presence in the F1 thymus of a y
radiation-resistant, dGua-sensitive population of cells which are not T cell
precursors . When this population is replaced with cells of the BB-DP lineage, the
T cells that mature in this thymus exhibit the functional characteristics of the
BB-DP marrow donor rather than the F 1 thymus donor . Therefore F 1 T cell
precursors maturing in a BB thymus containing BB marrow-derived cells should140
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TABLE IV
Comparison ofMixed Leukocyte Responses between FlatxbmBBx and
FlatxbmBBdGua at 7 wk after Transplantation
* Number ofresponder cells X 10-5 perwell.
$Values refer to the mean cpm of triplicate cultures; the SE did not exceed 10% of
the mean.
exhibit the T cell functions of the BB-DP thymus donor. Conversely, if the BB
thymus is treated with dGua, the T cells that mature should exhibit the functions
of the F1 marrow donor.
To test this, DA/BB F l animals were made into atxbm animals as described
in Materials and Methods. Animals were transplanted with -y-irradiated or dGua-
treated BB thymus grafts. Representative data from an animal in each group
tested at 7 wk after thymus transplant are shown in Table IV. TDLs from the
FlatxbmBBdGua animal proliferated comparably to those from a normal PVG
rat in response to third-party strain Fisher stimulator cells. FlatxbmBBx prolif-
erated poorly in response to Fisher. Neither thymus-transplanted F l animal
responded to strain DA stimulator cells when their proliferative responses were
compared with those without any stimulators in the cultures.
This experiment shows that otherwise normal F 1 T cell precursors proliferate
in a manner similar to BB-DP T cells if they mature in a BB-DP thymus which
contains dGua-sensitive BB-DP cells. Elimination of these dGua-sensitive BB-DP
cells results in the return of normal T cell function. The return of normal T cell
function is presumably mediated by the repopulation of the BB thymus with
dGua-sensitive F1 cells.
Response of Thymus-transplanted Animals at 16 wk.
￿
Longo and Schwartz were
the first to propose that T cell specificity was influenced by the phenotype of
thymic APCs (20). They examined turnover of thymic APCs and concluded that
APCs of the marrow donor haplotype could be detected in the thymus by 2 mo
and that the new T cells emerging after that time behaved like the marrow
rather than the thymus donor.
We tested whether T cells from thymus-transplanted animals exhibited the T
cell functions of the marrow donor 16 wk after thymus transplantation when it
Responder TDL Responder
cells*
Stimulator
Fisher
cells(3 X 105
DA
cells/well)
None
PVG(unmanipulated) 3.0 137,242$ 81,751 7,831
1.5 130,269 94,378 2,217
0.75 90,300 57,720 1,886
BB-DP(unmanipulated) 3.0 4,281 6,074 2,585
1.5 1,131 4,007 938
0.75 685 3,669 385
FlatxbmBBdGua 3.0 117,990 18,589 20,963
1.5 113,377 11,308 14,544
0.75 53,281 3,167 1,125
FlatxbmBBx 3.0 24,713 2,585 4,686
1.5 19,303 657 896
0.75 15,058 150 338M
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(A) Mixed leukocyte proliferative responses were compared between normal DA
and thymus-transplanted BBatxbmBBx andBBatxbmFlx rats. TDLs were tested 16 wk after
thymus transplantation. (B) The data from A are replotted to correct for the percentage of
respondercellsthat are OX-19+(pan T cell marker). BB+O refers to the proliferative response
of BB TDLs without theaddition of allogeneic (Fisher) stimulators.
might be expected that the thymus transplants would be repopulated with
marrow-derived radiation-resistant, dGua-sensitive cells.
When the same experiment as described in Fig. 1 was repeated in two
BBatxbmFlx animals at 16-wk after thymus grafting, their TDL proliferative
response remained enhanced. However, it was obviously less than that of TDLs
from normal diabetes-resistant strains (Fig. 4A). In this experiment we also
included a BBatxbm transplanted with a -y-irradiated BB thymus (BBatxbmBBx).
The response of the TDLs from this animal mirrored that of the unmanipulated
BB-DP rats showing that the experimental procedures of adult thymectomy,
lethal irradiation, and bone marrow reconstitution are not themselves factors in
the improved proliferative response. Data manipulations to correct for the
percentage of OX-19+ cells did not lead to the suggestion that the responses of
T cells from these animals was comparable to normal rats on a cell-for-cell basis
(Fig. 4B) . Therefore the response with time after thymus transplantation appears
to be moving towards that of the BB-DP marrow donor.
Similarly, FlatxbmBBx have responses in the normal range and mirror those
observed for FlatxbmBBdGua at 16 wk (Table V). Again, the proliferative
response of the T cells from these animals approximates that observed for the
F1 marrow donor.
Two BBatxbmFIdGua were also tested at 16 wk after thymus transplant. The
collected TDLs were tested for proliferative responses to alloantigen. The results,
shown in Fig. 5 were the same as those of identically treated animals tested at 7
wk. The proliferative responses were in the range observed for unmanipulated
BB-DP rats.
Summary of Data.
￿
Fig. 6 attempts to collate the data from all four groups
tested at 7 and 16 wk after thymus transplantation. Plateau cpm values from
each experimental animal are compared as a percentage of the cpm values of the
normal rats used as controls in the same experiment. The closer the value
approaches 100% the more the experimental animals response approximates14 2
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TABLE V
Comparison ofMixedLeukocyteResponses between FlatxbmBBx and
FlatxbmBBdGua at 16 wk after Transplantation
Discussion
5 torces (3 X 10ces/wel) llll
* Number ofresponder cells X 10-5 per well .
$ Values refer to the mean cpm of triplicate cultures ; the SE did not exceed 10% of
the mean .
FIGURE 5 . Mixed leukocyte
proliferative responses are
compared between TDLs
from normal PVG, BB-DP,
and BBatxbm rats trans-
planted with dGua-treated
DA/BB F1 thymus (BBatxbm-
F1dGua) . TDLs were tested
16 wk after thymus transplan-
tation .
that of a normal nondiabetes-prone rat . As can be observed diagramatically, the
BBatxbmF 1x response approaches the range ofnormal rats at 7wk after thymus
transplant and is deteriorating by 16 wk . Conversely, the F latxbmBBx responses
are in the range of untreated BB-DP at 7 wk and improve to normal levels by
16 wk . BBatxbmFldGua remain constant at the levels observed for BB-DP and
FlatxbmBBdGua remain at levels observed for normal DA/BB F1 rats .
Adult thymectomized, lethally irradiated, and bone marrow-reconstituted BB-
DP rats were transplanted with thymus tissue from DA/BB F1 fetal donors . The
thymus tissue was subjected to ,y irradiation before transplantation to kill resident
F 1 thymocytes . The thoracic duct lymphocytes from these thymus-transplanted
ResponderTDL Responder
cells
Stimul
Fisher
PVG(unmanipulated) 3.0* 160,124*
1 .5 61,847
0.75 18,527
FlatxbmBBdGua No. 1 3.0 160,788
1 .5 84,893
0.75 18,746
2 3.0 138,855
1 .5 92,926
0.75 34,346
FlatxbmBBx No. 1 3.0 154,541
1 .5 94,379
0.75 30,413
2 3.0 131,959
1 .5 92,627
0.75 47,472
DA None
142,584 251
49,687 90
6,447 88
19,935 14,439
1,501 8,760
353 2,029
8,973 9,919
543 7,010
109 973
22,858 25,769
8,386 7,943
803 1,746
12,710 12,233
1,316 2,327
240 506a
c
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FIGURE 6. On the x axis,.
BB-DP TDLs are compared
with BB and DA/BB F1 ani-
mals transplanted with thymus
tissue 7 or 16 wk before test-
ing. The y axis (% of normal)
was derived by dividing the
maximum cpm observed for
the BB-DP or thymus-trans-
planted animals by the maxi-
mum cpm of the normal, non-
diabetes-prone animal used as
a control in each experiment.
Maximum cpm is the ['H]thy-
midine incorporation of lym-
phocytes from each animal
stimulated with the same
MHC-incompatible popula-
tions for 4 d as described in
Materials and Methods.
animals (BBatxbmFIx) were compared with those from normal DA/BB F1 and
unmanipulated BB-DP rats for their proliferative responses to alloantigen .
Whereas TDLs from the unmanipulated BB-DP animals displayed the typical T
cell dysfunction (i.e., a very weak proliferative response to alloantigen; Table I),
TDLs from the thymus-transplanted BBatxbmF 1x animals generated prolifera-
tive (Fig. 1 A) responses which far exceeded responses of BB-DP. On a cell-for-
cell basis the OX-19' T cell responses of the normal and thymus-grafted animals
appeared comparable in two of three examples tested (Fig. 1 B). This first
experiment performed at 7 wk after thymus transplant was repeated at 16 wk.
By this time, the responses, though obviously better than those from normal BB-
DP rats, appeared to be diminishing compared with normal diabetes-resistant
rats (Fig. 4A) regardless of any corrections made for the percentage of OX19+
T cells (Fig. 4B).
When the same experiment was performed with TDLs from animals that had
been transplanted 7 wk previously with F1 thymus tissue treated with dGua, the
proliferative responses ofthe BBatxbmF1 dGua thymus-grafted animals remained
poor (Fig. 3) and in the range observed for BB-DP TDLs. It did not improve in
animals tested at 16 wk after thymus transplant. It has been shown by others
that dGua is toxic for bone marrow-derived cells but spares the thymic epithelial
cells.
We conclude from these experiments that the proliferative defect to alloanti-
gen observed in the BB-DP rat is not preprogrammed at the level of T cell
precursors in the bone marrow. It wouldappear instead that BB T cell precursors
can function normally if they mature in a thymus containing a radiation-resistant,
dGua-sensitive population of thymic immigrants from normal strains. The liter-
ature suggests these immigrants are APCs (20) that are most likely macrophage
and/or dendritic cells (17-19), hereafter referred to as thymic APCs. If this
population of cells is destroyed and replaced with thymic immigrants of BB-DP
origin, then the T cell precursors that mature in the chimeric-thymic environ-
ment express the functional phenotype of the marrow donor.
The results with T cell-depleted F 1 animals transplanted with BB tissue are144
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consistent with this hypothesis. Flatxbm transplanted with a dGua-treated BB
thymus graft have normal T cell proliferative responses (Table IV). This shows
that dGua does not destroy the capacity of the tissue to provide the thymic
environment necessary for T cell maturation . It is also consistent with the
hypothesis that BB thymus tissue appears to perform normally if repopulated
with Fl thymic APCs (a bone marrow-derived, radiation-resistant, dGua-sensi-
tive thymic immigrant). If the BB thymus contains BB thymic APCs, the results
appear to be different. We observed a weak proliferative response in Flatxbm
rats transplanted with BB 7-irradiated thymus tissue (Table IV) but this response
returns to normal by 16 wk after transplantation (Table V) . Our explanation for
the rapid recovery of T cell function is that the BB thymus becomes repopulated
with F1 thymic APCs. To prevent this we are presently repeating these experi-
ments with the addition of Flatx injected with BB bone marrow before BB
thymus transplantation. In this latter case, the T cell dysfunction should be
evident because the BB thymus will be repopulated with BB thymic APCs.
The BBatxbm thymus-transplanted animals remained lymphopenic with re-
duced numbers of OX-19+ mature T lymphocytes and class II MHC reactive
(W3/25+) T cells, and few, if any, class I MHC reactive (OX-8+) T cells (Table
II). Therefore, the lymphopenia appears to be nascent in the bone marrow and
is not influenced by the thymus. Conversely, we have observed that Flatxbm
with BB tissue are not lymphopenic (data not shown).
In other studies it can be concluded that the T cell dysfunction in the BB-DP
rat is separablefrom the lymphopenia(8)and that the lymphopenia has its origins
in the marrow (10). Our results are in agreement on these points. However, we
also conclude that the T cell dysfunction is influenced by the thymus and on this
issue our results appear to be at odds with another study (10). In that study
BBatxbm were transplanted with BB diabetes-resistant thymus grafts. When
these animals were tested later (at least 12 wk after transplantation), the TDLs
functioned like the diabetes-prone marrow donor, i.e ., the proliferative dysfunc-
tion remained. There are several possible explanations for the differences be-
tween their results and ours . The one we prefer is that, in the former study,
there was an influence of the diabetes-resistant thymus graft but that it was not
observed due to the time of assay after grafting. It would appear that the longer
one waits to test for T cell function after transplantation the more the response
appears to express the phenotype of the marrow donor. A similar conclusion was
made earlier by Longo and Schwartz who studied the MHC-restricted T cell
profile of thymic chimeras with time after transplantation (20). Other possible
explanations for the differences in results are as follows: (a) we transplanted
semiallogeneic F1 thymus grafts while they used an MHC-compatible diabetes-
resistant strain . Perhaps the differences at the MHC are important to correct the
dysfunction; (b) our animals are SPF while theirs were conventionally reared.
Conceivably some immunosuppressive effect of pathogen infection may have
influenced their proliferation data.
It seems unlikely that the proliferative responses observed after transplantation
of an F1 thymus is due to F1 thymocyte contamination. The most direct evidence
is that the transplanted animals do not appear to be chimeric for F1 lymphocytes
(Table III). One must also hypothesize that such F1 thymocytes are resistant toGEORGIOU ET AL.
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2,000 rad of irradiation to which the thymus tissue was subjected before trans-
plantation.
Ofinterest to this report is the observation that BB rats lack the OX-19+/OX-
8+ class I-reactive Tcell subset. The absence ofthis population providesa likely
explanation why CTLs are difficult to generate in the BB-DP rat (6). Because
the BBatxbmFI thymus-grafted animals remained lymphopenic with few, ifany
OX-8+ cells, it is conceivable that the CTL response observed is due to the
W3/25+ subset. Alternatively, the very few OX-19+/OX-8' cells may expand
sufficiently over the 6 d of culture to account for the response. This is our
preferred explanation for the CTL activity. We have observed that normal
thymectomized and T cell-depleted rats, while having essentially background
levels of OX-8' cells at three wk after transplantation of a syngeneic thymus,
generate good CTLs on a cell-for-cell basis in vitro (our unpublished data). By
12 wk these animals have ratios of W3/25 to OX-8 that approach the normal
(2:1) range. Experiments have been designed to test the phenotype of the CTLs
in BBatxbmF 1x.
For technical reasons we were only able to test one of the BBatxbmF 1dGua
animals for CTL activity. TDLs from thisanimal could generate detectable CTL
activity to third-party alloantigens. Interestingly, TDLs from this animal also
generated CTLs to "thymic self" DA alloantigens but only when the cultures
were supplemented with exogenous sources of IL-2 (unpublished data). We
observed no proliferation with stimulators of the DA haplotype in any of the
animals transplanted with an F1 thymus whether the thymus was subjected to -Y
irradiation or dGua treatment. Perhaps the T cells that proliferate early in
response to alloantigen provide the necessary lymphokines required to activate
the CTL precursors (15). Apparently these cells are tolerized in the F1dGua
thymus which would explain why CTLs to DA areonly generated in the presence
of exogenous sources of help. If confirmed with more animals the result with
the dGua-treated thymus supports the conclusions in the murine model that the
class I-reactive T cells are not tolerized when the class I antigen is expressed
only on the thymic epithelium (19).
The deterioration of normal T cell function in BBatxbm with 'Y-irradiated F1
thymus grafts (Fig. 4,A and B) has interesting implications. It could simply mean
that the early functional T cells become diluted by abnormal "diabetes-prone" T
cells. It is also possible that BB-DP T cells are dominant and can influence the
function of normal Tcells. The evidence thus far is mostly against this. Addition
of BB-DP T cells to normal T cell proliferation assays has not resulted in
suppression (5). Also, normal mature T cells present in a bone marrow inoculum
can function normally in the BB-DP environment (7, 8), which argues against a
suppressive influence of the BB-DP environment on mature T cells. However,
bone marrow inocula containing T cell precursors from normal, diabetes-resist-
ant donors does not prevent diabetes if it is depleted of mature T cells before
injection into BB-DP neonates (8) suggesting a potent influence of the BB-DP
environment on Tcell precursors.
T cell function may be influential in determining the susceptibility of BB rats
to diabetes. The best experiments to support this statement are those in which
BB-DP animals are protected from disease development after inoculation with146
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cells from nondiabetes-prone donors (7-9). Prevention of disease in BB-DP
animals inoculated with normal cells correlates with a return of normal T cell
function (7, 8). Interestingly, thediabetes-resistant BB-DRrat (4, 21) also appears
to have normal T cell proliferative responses (Table I). So far, the only animals
in our thymus transplant study which have developed diabetes are those which
express the T cell dysfunction.
The prevailing view at the moment is that two important roles of the thymus,
imprinting MHC restriction and thegeneration ofself-tolerance are orchestrated
by different cells in the thymus. Tolerance is heavily influenced by marrow-
derived cells which are not T cell precursors and MHC restriction can occur
when the MHC-restricting elements are presented only on the thymic epithelium.
Because the T cell dysfunction is dependent on the presence of BB-DP radiation-
resistant cells, this may have important implications for the development of
diabetes. It could suggest that self-tolerance induction is aberrant in the BB-DP
rat and this in some way leads to the destruction of pancreatic islets. However it
appears, based on the reduced numbers of T cells, the weak MLR, and non-
existent CTLs that if there is an aberration in tolerance induction, it leans toward
increased rather than decreased tolerance. The increased tolerance could result
from hyperexpression of MHC antigen in the thymus mediated by BB-DP
marrow-derived cells. The increased tolerance could explain the absence of class
I-reactive T cellsand the reduced MLR. Casualties of this overzealous tolerance
might also include T cells important in regulatory or suppressor function.
Summary
Diabetes-prone BB (BB-DP) rats express several T cell dysfunctions which
include poor proliferative and cytotoxic responses to alloantigen. The goal of
this study was to determine the origin of these T cell dysfunctions. When BB-
DP rats were thymectomized, T cell depleted, and transplanted with neonatal
thymus tissue from diabetes-resistant and otherwise normal DA/BB F1 rats, the
early restoration of T cell function proceeded normally on a cell-for-cell basis;
i.e., peripheral T cells functioned like those from the thymus donor. Because the
thymus in these experimentswassubjected to y irradiation before transplantation
and there was no evidence of F1 chimerism in the transplanted BB-DP rats, it
appeared that the BB-DP T cell precursors could mature into normally function-
ing T cells if the maturation process occurred in a normal thymus. If the F1
thymus tissue was treated with dGua before transplantation, the T cells of these
animals functioned poorly like those from untreated BB-DP rats. dGua poisons
bone marrow-derived cells, including y radiation-resistant cells of the macro-
phage/dendritic cell lineages, while sparing the thymic epithelium. Therefore,
the reversal of the T cell dysfunction depends on the presence in the F1 thymus
of y radiation-resistant, dGua-sensitive F1 cells. Conversely, thymectomized and
T cell-depleted F1 rats expressed T cell dysfunction when transplanted with -y-
irradiated BB thymus grafts. T cell responseswere normal in animalstransplanted
with dGua-treated BB thymus grafts. With increasing time after thymus trans-
plantation, T cells from all animals gradually expressed the functional phenotype
of the bone marrow donor. Taken together these results suggest that BB-DPGEORGIOU ET AL.
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bone marrow-derived cells that are not T cell precursors influence the matura-
tion environment in the thymus of otherwise normal BB-DP T cell precursors.
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